zonisamide has been researched along with Cardiac Hypertrophy in 2 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tian, JH | 2 |
| Wu, Q | 2 |
| He, YX | 2 |
| Shen, QY | 1 |
| Rekep, M | 1 |
| Zhang, GP | 2 |
| Luo, JD | 2 |
| Xue, Q | 2 |
| Liu, YH | 2 |
| Huang, YY | 1 |
| Huang, YQ | 1 |
| Yu, XY | 1 |
2 other studies available for zonisamide and Cardiac Hypertrophy
| Article | Year |
|---|---|
Zonisamide, an antiepileptic drug, alleviates diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress.
Topics: Animals; Anticonvulsants; Apoptosis; Blood Glucose; Body Weight; Cardiomegaly; Diabetes Mellitus, Ty | 2021 |
Zonisamide alleviates cardiac hypertrophy in rats by increasing Hrd1 expression and inhibiting endoplasmic reticulum stress.
Topics: Animals; Aorta, Abdominal; Apoptosis; Cardiomegaly; Endoplasmic Reticulum Stress; Endoplasmic Reticu | 2021 |